சிமோன் மூரோனி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிமோன் மூரோனி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிமோன் மூரோனி Today - Breaking & Trending Today

Synthetic Pitch The Top Priority For Caherlohan Working Group


Home » Breaking News » Synthetic Pitch The Top Priority For Caherlohan Working Group
A general view of the senior football training pitch at The Clare GAA Centre Of Excellence in Caherlohan. Photograph by John Kelly
Synthetic Pitch The Top Priority For Caherlohan Working Group
April 29, 2021
The chairperson of the group tasked with working toward a plan to address the issues at Clare GAA’s Centre of Excellent has outlined the three main priorities to begin that process.
The much maligned €4.8 million venue at Caherlohan has been the subject of intense scrutiny and discussion over the last few months, with clubs being invited to visit the facility for themselves last weekend before making any submissions to the new strategic group for the future of Clare GAA. ....

Simon Moroney , Munster Council , Centre Of Excellence , Centre Of Excellent , Clare Champion , Cusack Park , Wolfe Tones , சிமோன் மூரோனி , மன்ஸ்டர் சபை , மையம் ஆஃப் சிறப்பானது , மையம் ஆஃப் சிறந்தது , தெளிவு சாம்பியன் , க்யூஸக் பூங்கா , ஓநாய் டன் ,

Biotalys Appoints Simon Moroney as Chairman of the Board



Biotalys, an AgTech company focused on addressing food protection challenges to enable a more sustainable and safer food supply, is pleased to announce the appointment of Simon Moroney as Chairman of the Board, following the Company’s Annual General Meeting end of last week.
Simon brings over 30 years of industry leadership and research experience to the Biotalys Board. From 1992 to 2019, he was co-founder and CEO of MorphoSys, a leading biotechnology company focused on the treatment of cancer and autoimmune diseases. At MorphoSys, Simon played a central role in establishing the company as a driving force in the field of therapeutic antibodies and led the company to a $239m initial public offering on the Nasdaq stock exchange in 2018. He currently sits on the board of Novartis as a non-executive Director. Simon has been recognized and awarded with the German Cross of the Order of Merit for his work and contribution to the biotechnology industry. ....

Biotalysappoints Simon Moroney , Appoints Simon Moroney , Simon Moroney , Annual General Meeting , German Cross , Simon Moroney , Atrice Sell 232 S , Agricultural Technology , சிமோன் மூரோனி , ஆண்டு ஜநரல் சந்தித்தல் , ஜெர்மன் குறுக்கு ,